NCT06793020 Diagnosis, Treatment, and Outcome Assessment of Septic Cardiomyopathy Using an Integrated Mathematical Model
| NCT ID | NCT06793020 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vilnius University |
| Condition | Septic Cardiomyopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-03-17 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-03-17 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate whether a new integrated mathematical model can improve the accuracy of diagnosing septic cardiomyopathy and predicting clinical outcomes in adult patients with suspected septic cardiomyopathy. The study aims to determine whether the integrated mathematical model enhances diagnostic accuracy and improves the prediction of clinical outcomes in these patients.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older; * Sepsis according to SEPSIS-3 criteria: * Suspected/confirmed infection and * SOFA (Sequential Organ Failure Assessment) score ≥ 2 or qSOFA score ≥ 2; * Septic shock according to SEPSIS-3 criteria: * Sepsis is diagnosed and * Vasopressor infusion is used to maintain a mean arterial pressure (MAP) ≥ 65 mmHg and * Lactate \> 2 mmol/l; * Cardiovascular support requirement for norepinephrine \> 0.1 mcg/kg/min infusion; * Signed informed consent form (ICF); Exclusion Criteria: * Individuals under 18 years of age; * Has uncompensated cardiovascular disease: * Cardiogenic shock; * Congenital heart disease; * Heart failure NYHA functional class IV; * Refusal to participate in the study.
Frequently Asked Questions
Who can join the NCT06793020 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Septic Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793020 currently recruiting?
Yes, NCT06793020 is actively recruiting participants. Visit ClinicalTrials.gov or contact Vilnius University to inquire about joining.
Where is the NCT06793020 trial being conducted?
This trial is being conducted at Vilnius, Lithuania, Warsaw, Poland.
Who is sponsoring the NCT06793020 clinical trial?
NCT06793020 is sponsored by Vilnius University. The trial plans to enroll 100 participants.